Clinical Trials Directory

Trials / Completed

CompletedNCT06345638

Sex Hormones and Inflammatory Biomarkers in Patients With Sickle Cell Disease

Status
Completed
Phase
Study type
Observational
Enrollment
52 (actual)
Sponsor
University of Pennsylvania · Academic / Other
Sex
All
Age
18 Years – 45 Years
Healthy volunteers
Not accepted

Summary

This study aims to characterize sex differences in the pathophysiology of vaso-occlusive crises (VOC) occurring among individuals with sickle cell disease (SCD). * The study will compare CRP and other biomarkers between females with SCD in the follicular phase of the menstrual cycle and males with SCD. * The study will explore potential sex differences in biomarker changes between females and males with SCD during and following resolution of VOC. * The study will compare neutrophil and platelet adhesion to the endothelium and real time fibrin deposition in the blood.

Conditions

Timeline

Start date
2024-03-01
Primary completion
2025-06-17
Completion
2025-06-17
First posted
2024-04-03
Last updated
2025-08-05

Locations

3 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT06345638. Inclusion in this directory is not an endorsement.

Sex Hormones and Inflammatory Biomarkers in Patients With Sickle Cell Disease (NCT06345638) · Clinical Trials Directory